UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): September 8, 2011
REDPOINT BIO CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
|
000-51708 |
|
22-3393959 |
|
(State of Incorporation) |
|
(Commission File No.) |
|
(IRS Employer ID No.) |
Redpoint Bio Corporation
7 Graphics Drive
Ewing, New Jersey 08628
(Address of Principal Executive Offices)
(609) 637-9700
Registrant’s Telephone Number, Including Area Code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 8, 2011, Leif Kjaergaard, Ph.D., resigned as a member of the Board of Directors (the “Board”) of Redpoint Bio Corporation, a Delaware corporation (the “Company”), member of the Compensation Committee of the Board, and member and chairman of the Nominating and Corporate Governance Committee of the Board, effective immediately. There is no disagreement between Dr. Kjaergaard and the Company on any matter relating to the Company’s operations, policies or practices.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
REDPOINT BIO CORPORATION | |
|
|
|
|
|
Dated: September 13, 2011 |
|
|
|
|
|
|
|
|
By: |
/s/ Scott Horvitz |
|
|
Name: |
Scott Horvitz |
|
|
Title: |
Chief Financial Officer, Treasurer and Secretary |